Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

INTRODUCTION: Fingolimod 0.5 mg is an orally active sphingosine 1-phosphate receptor modulator approved for use in adults with relapsing multiple sclerosis (MS). The efficacy and safety profile of fingolimod has been well characterized in a large clinical development program. Here, we report the saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordoñez-Boschetti, Laura, Rey, Roberto, Cruz, Ana, Sinha, Arijit, Reynolds, Tracy, Frider, Nadina, Alvarenga, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522027/
https://www.ncbi.nlm.nih.gov/pubmed/26170105
http://dx.doi.org/10.1007/s12325-015-0224-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522027/
https://www.ncbi.nlm.nih.gov/pubmed/26170105
http://dx.doi.org/10.1007/s12325-015-0224-2

Ejemplares similares